Zentalis Pharmaceuticals, Inc.
ZNTL- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001725160
In the last 90 days, Zentalis Pharmaceuticals, Inc. insiders filed 1 open-market purchase and 0 sales; 114 institutions reported holding it in 13F filings for Q2 2026, worth $228.9M in total; no superinvestor holds it.
13F holders, Q3 2023
Institutional positions in Zentalis Pharmaceuticals, Inc. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 137
- +4 vs. Q2 2023
- Shares held
- 80.2M
- −2.22M (−2.7%) vs. Q2 2023
- Total value
- $1.61B
- −$713.7M (−30.7%) vs. Q2 2023
- New holders
- 17
- 52 more added
- Sold out
- 13
- 39 more reduced
1 institution that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ZNTL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 114 | $228.9M |
| Q1 2026 | 102 | $101.7M |
| Q4 2025 | 86 | $54.9M |
| Q3 2025 | 99 | $79.7M |
| Q2 2025 | 117 | $64.5M |
| Q1 2025 | 132 | $92.9M |
| Q4 2024 | 142 | $195.2M |
| Q3 2024 | 136 | $261.2M |
| Q2 2024 | 145 | $314.3M |
| Q1 2024 | 142 | $1.34B |
| Q4 2023 | 120 | $1.23B |
| Q3 2023 | 137 | $1.61B |
| Q2 2023 | 134 | $2.32B |
| Q1 2023 | 110 | $1.15B |
| Q4 2022 | 106 | $1.30B |
| Q3 2022 | 121 | $1.27B |
| Q2 2022 | 122 | $1.64B |
| Q1 2022 | 128 | $2.05B |
| Q4 2021 | 139 | $3.61B |
| Q3 2021 | 116 | $2.75B |
| Q2 2021 | 120 | $2.13B |
| Q1 2021 | 95 | $1.58B |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding Zentalis Pharmaceuticals, Inc.; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| ProShare Advisors LLC | 12,183 | $244.4K | 0.00% | +1,946+19.0% | Added |
| Graham Capital Management, L.P. | 10,600 | $212.6K | 0.01% | +10,600 | New |
| E Fund Management Co., Ltd. | 10,307 | $207.0K | 0.02% | −3,185−23.6% | Reduced |
| Prelude Capital Management, LLC | 10,190 | $204.4K | 0.02% | +173+1.7% | Added |
| GTS Securities LLC | 9,987 | $200.3K | 0.00% | +9,987 | New |
| Erste Asset Management GmbH | 9,800 | $192.4K | 0.00% | 00.0% | Unchanged |
| Amalgamated Bank | 8,484 | $170.0K | 0.00% | +1,011+13.5% | Added |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 7,809 | $156.6K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 7,649 | $154.0K | 0.00% | +4,353+132.1% | Added |
| Ameritas Investment Partners, Inc. | 5,837 | $117.1K | 0.00% | +1,780+43.9% | Added |
| Great West Life Assurance Co | 5,018 | $101.0K | 0.00% | +3,839+325.6% | Added |
| Exchange Traded Concepts, LLC | 4,470 | $89.7K | 0.00% | −1,184−20.9% | Reduced |
| Virtus ETF Advisers LLC | 4,012 | $80.5K | 0.05% | −403−9.1% | Reduced |
| Metropolitan Life Insurance Co | 3,388 | $68.0K | 0.00% | +703+26.2% | Added |
| Simplex Trading, LLC | 2,213 | $44.0K | 0.00% | +2,213 | New |
| China Universal Asset Management Co., Ltd. | 1,809 | $36.3K | 0.01% | +1,030+132.2% | Added |
| Advisor Group Holdings, Inc. | 1,294 | $26.0K | 0.00% | +647+100.0% | Added |
| Tower Research Capital LLC (TRC) | 1,026 | $20.6K | 0.00% | −5,894−85.2% | Reduced |
| Amundi | 1,060 | $20.1K | 0.00% | −3,329−75.8% | Reduced |
| KBC Group NV | 904 | $18.0K | 0.00% | +904 | New |
| Cutler Group LP | 900 | $18.0K | 0.00% | +900 | New |
| US Bancorp | 887 | $17.8K | 0.00% | 00.0% | Unchanged |
| Nisa Investment Advisors, LLC | 565 | $11.3K | 0.00% | −1,020−64.4% | Reduced |
| Lindbrook Capital, LLC | 416 | $8.35K | 0.00% | 00.0% | Unchanged |
| Daiwa Securities Group Inc. | 212 | $4.00K | 0.00% | 00.0% | Unchanged |
| CWM, LLC | 137 | $3.00K | 0.00% | 00.0% | Unchanged |
| Comerica Bank | 143 | $2.87K | 0.00% | +143 | New |
| EverSource Wealth Advisors, LLC | 141 | $2.83K | 0.00% | 00.0% | Unchanged |
| HighMark Wealth Management LLC | 130 | $2.61K | 0.00% | 00.0% | Unchanged |
| Bogart Wealth, LLC | 125 | $2.51K | 0.00% | 00.0% | Unchanged |
| Proequities, Inc. | 100 | $2.01K | 0.00% | 00.0% | Unchanged |
| Red Tortoise LLC | 83 | $1.67K | 0.00% | 00.0% | Unchanged |
| Bell Investment Advisors, Inc | 76 | $1.52K | 0.00% | 00.0% | Unchanged |
| Signaturefd, LLC | 51 | $1.02K | 0.00% | −12−19.0% | Reduced |
| FinTrust Capital Advisors, LLC | 17 | $335 | 0.00% | +17 | New |
| Allworth Financial LP | 7 | $141 | 0.00% | −1−12.5% | Reduced |
| Covestor Ltd | 5 | $0 | 0.00% | 00.0% | Unchanged |
| Deep Track Capital, LP | 0 | $0 | 0.00% | −300,300−100.0% | Sold out |
| EcoR1 Capital, LLC | 0 | $0 | 0.00% | −300,000−100.0% | Sold out |
| Jefferies Financial Group Inc. | 0 | $0 | 0.00% | −93,900−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −31,570−100.0% | Sold out |
| Skandinaviska Enskilda Banken AB (publ) | 0 | $0 | 0.00% | −22,800−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −18,410−100.0% | Sold out |
| NinePointTwo Capital | 0 | $0 | 0.00% | −10,716−100.0% | Sold out |
| Bridgefront Capital, LLC | 0 | $0 | 0.00% | −10,560−100.0% | Sold out |
| Handelsbanken Fonder AB | 0 | $0 | 0.00% | −8,300−100.0% | Sold out |
| Bayesian Capital Management, LP | 0 | $0 | 0.00% | −8,011−100.0% | Sold out |
| Fox Run Management, L.L.C. | 0 | $0 | 0.00% | −7,760−100.0% | Sold out |
| Scharf Investments, LLC | 0 | $0 | 0.00% | −7,531−100.0% | Sold out |
| Ronald Blue Trust, Inc. | 0 | $0 | 0.00% | −7−100.0% | Sold out |
| Tekla Capital Management LLC | – | – | – | – | Not filed |